Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsaleh

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 6, 2000
Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?H Elsaleh, P Robbins, D Joseph, et al.
The Pharmacogenomics Journal|June 1, 2011
Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704J J Farrell, K Bae, J Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effectsQuoc-Chuong Bui, Michael Lieber, H Rodney Withers, et al.
Plos One|June 30, 2021
Temporal determinants of tumour response to neoadjuvant rectal radiotherapyKendrick Koo, Rachel Ward, Ryan L Smith, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patientsD M Severin, T Leong, B Cassidy, et al.
Chronobiology International|March 30, 2017
Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?Tim Squire, Grant Buchanan, David Rangiah, et al.
Oncology|April 17, 2003
Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancerCathy Wang, Marius van Rijnsoever, Fabienne Grieu, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2000
Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutationR Soong, B Powell, H Elsaleh, et al.
Breast Cancer Research and Treatment|January 5, 2002
Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patientsB L Powell, S Bydder, F Grieu, et al.
The Medical Journal of Australia|June 9, 2000
Internet use by radiation oncology patients: a pilot studyC C Duffy, N F McLernon, L J D'Orsogna, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 6, 2000
Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?H Elsaleh, P Robbins, D Joseph, et al.
The Pharmacogenomics Journal|June 1, 2011
Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704J J Farrell, K Bae, J Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effectsQuoc-Chuong Bui, Michael Lieber, H Rodney Withers, et al.
Plos One|June 30, 2021
Temporal determinants of tumour response to neoadjuvant rectal radiotherapyKendrick Koo, Rachel Ward, Ryan L Smith, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patientsD M Severin, T Leong, B Cassidy, et al.
Chronobiology International|March 30, 2017
Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?Tim Squire, Grant Buchanan, David Rangiah, et al.
Oncology|April 17, 2003
Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancerCathy Wang, Marius van Rijnsoever, Fabienne Grieu, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2000
Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutationR Soong, B Powell, H Elsaleh, et al.
Breast Cancer Research and Treatment|January 5, 2002
Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patientsB L Powell, S Bydder, F Grieu, et al.
The Medical Journal of Australia|June 9, 2000
Internet use by radiation oncology patients: a pilot studyC C Duffy, N F McLernon, L J D'Orsogna, et al.
Pageof 7